Diabetes drug pipeline boasts close to 200 medications
WASHINGTON Nearly 200 drugs are in the pipeline as possible treatments for diabetes, according to an article in a Colorado newspaper.
The Pharmaceutical Research and Manufacturers of America heralded the article, which was published in the Stratton Spotlight of Stratton, Colo., and based on a survey by the Centers for Disease Control and Prevention. It reported that drug companies were working on 183 new drugs for diabetes, including 133 for Type 2 diabetes, 26 for Type 1 diabetes and 34 for other forms of the disease and related conditions, such as gestational diabetes.
“The diabetes medicines now in the research pipeline are contributing substantially to the incredible progress made in the last five years by biopharmaceutical companies in developing new and more effective diabetes treatments,” PhRMA president and CEO Billy Tauzin said in a statement. “The nation must continue its strong commitment to the cutting-edge pharmaceutical research that enables today’s diabetes patients to manage their disease and lead productive lives.”
Duane Reade opens fifth walk-in medical clinic in New York
NEW YORK A new walk-in clinic at a Duane Reade store in Chelsea officially opened on Wednesday, making it the fifth Duane Reade location with “Doctor on Premises” walk-in medical care.
The physician-staffed clinic is managed by Consumer Health Services and is also affiliated with Beth Israel Medical Center and St. Luke’s-Roosevelt Hospital Center. It is open Monday through Saturday, 10 a.m. to 6 p.m., and accepts most insurance plans.
“Walk-in, neighborhood-based medical care is a growing trend in this country, and it’s a very positive trend,” stated Dr. Maggie Bertisch, M.D., medical director for New York Walk-In Medical Group PC. “It allows healthcare providers to offer a more convenient, affordable alternative to crowded emergency rooms, while delivering safe, quality medical care in a New York minute.” According to CHS, Duane Reade is planning to add more on-site health clinics in 2010.
As reported, Walgreens, which owns retail-based clinic operator Take Care Health Systems, announced on Wednesday that is has reached an agreement to buy Duane Reade in a deal valued at nearly $1.1 billion.
Hi-Tech Pharmacal, Mission Pharmacal to market new kidney stone treatment
AMITYVILLE, N.Y. Hi-Tech Pharmacal and Mission Pharmacal Co. are planning to market a new treatment for kidney stones to doctors starting in April, the drug maker announced Wednesday.
Under a license agreement between the two companies, Hi-Tech will promote UroCit-K 15mEq (potassium citrate) extended-release tablets to primary care physicians through subsidiary ECR Pharmaceuticals, while Mission will promote it to urologists. The drug is a twice-daily treatment.
“We are pleased to introduce another unique prescription branded product to the primary care market,” Hi-Tech president and CEO David Seltzer said in a statement. “UroCit-K 15mEq is a highly effective product, available in a convenient dosing regimen which will increase patient compliance.”